Browsing by 저자 : Hee Kyung Ahn
전체 결과 14건 중 1-14 번을 표시중입니다.
-
1
Article
A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy
Young-Woong Won
;
Jin-Hyoung Kang
;
Jung Hye Kwon
;
et al
2023
-
2
Article
Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01)
Eun Joo Kang
;
Yun-Gyoo Lee
;
Bhumsuk Keam
;
et al
2022
-
3
Article
Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01)
Yun-Gyoo Lee
;
Eun Joo Kang
;
Bhumsuk Keam
;
et al
2023
-
4
Article
Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer
Ho Jung An
;
Hyun Jeong Jeon
;
Sang Hoon Chun
;
et al
2022
-
5
Article
Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer
Soohyeon Lee
;
Kyunghee Park
;
Gun Min Kim
;
et al
2022
-
6
Article
Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer
Kyoungmin Lee
;
Jongwon Lee
;
Jungmin Choi
;
et al
2023
-
7
Article
Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01)
Yun-Gyoo Lee
;
Eun Joo Kang
;
Bhumsuk Keam
;
et al
2022
-
8
Article
Knowledge, attitudes, and behaviors toward fertility preservation in patients with breast cancer: A cross-sectional survey of physicians
Soo Yeon Baek
;
Kyung-Hun Lee
;
Sung-Bae Kim
;
et al
2023
-
9
Article
Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)
고수진
;
정경해
;
Gun Min Kim
;
et al
2020
-
10
Article
Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B)
Sung Hoon Sim
;
Jeong Eun Kim
;
Min Hwan Kim
;
et al
2022
-
11
Article
Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05.
김상위
;
민영주
;
Byoung-Yong Shim
;
et al
2021
-
12
Article
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
Shinkyo Yoon
;
Miso Kim
;
Yong Sang Hong
;
et al
2022
-
13
Article
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer
Hee Kyung Ahn
;
Sung Hoon Sim
;
Koung Jin Suh
;
et al
2022
-
14
Article
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01)
김성배
;
Bhumsuk Keam
;
Hee Kyung Ahn
;
et al
2020